Like everyone, the Health Action International (HAI) team has been operating a little differently in the passed few months as a result of COVID-19.
We wanted to continue to share the work we’ve been doing during this time, and how each of the areas we work in have been impacted either directly or indirectly by COVID-19.
Our Facebook Live series focuses on each of our projects, as well as an overall look at HAI’s mission to advocate for a world with safe, effective, affordable and quality-assured medicines for everyone, everywhere in the time of COVID-19.
Even in normal circumstances, access to insulin is poor in many countries. The COVID-19 crisis makes the situation far worse, with national health systems overwhelmed and people forced to deal with the consequences of home confinement. Co-Lead of the ACCISS study, Dr Marg Ewen, discussed the current situation internationally to illustrate the reality for people who need insulin.
With a spotlight on Africa, Snakebite Project Manager Ben Waldmann discussed snakebite in the current and future COVID-19 context. This focused on the importance of community prevention and effective community engagement for dealing with snakebites, neglected tropical diseases during existing and future pandemics.
Executive Director, Dr Tim Reed, discussed HAI in the time of COVID-19, including the impact on us in practical terms and the impact on our work programmes, in particular as a result of social distancing measures for our partners in the South. Additionally, Tim discussed COVID-19 and governments’ response as a social determinant of health, support for WHO and how HAI is adjusting to the reality of COVID-19 in framing programmes.